Could an HIV drug protect new lungs after transplant?

This study tests whether Maraviroc, a drug already approved for HIV, can prevent a serious lung injury called primary graft dysfunction (PGD) after a lung transplant. PGD is a major cause of death in the first year after transplant, and there are no approved treatments for it. About 120 adults getting a double lung transplant will receive either Maraviroc or a placebo for 3 days after surgery. Researchers will compare how many develop severe PGD and how well they recover.